What causes the antiphospholipid syndrome?

被引:8
作者
Merrill J.T. [1 ]
机构
[1] Division of Rheumatology, St. Luke's-Roosevelt Hospital Center, Antenucci Building, 432 West 58th Street, New York, 10019, NY
关键词
Systemic Lupus Erythematosus; Factor Versus Leiden Mutation; Systemic Lupus Erythe; Lupus Anticoagulant; Mature High Density Lipoprotein;
D O I
10.1007/s11926-001-0033-2
中图分类号
学科分类号
摘要
The antiphospholipid syndrome (APS) is characterized by unpredictable, sporadic, thrombotic events. The cause of the thrombosis is probably multifactorial and may involve disparate effects of the autoantibodies associated with the syndrome, which are known to interfere with various protein regulators of hemostasis. An integrated theory of pathogenesis that accounts for the diversity of autoantibodies and their effects suggests that cellular inflammation or apoptosis within the vasculature may lead to oxidation or turnover in phospholipid membranes. Thus, normally cryptic, functionally important epitopes of phospholipid-binding proteins are subjected to increased exposure to immune surveillance.
引用
收藏
页码:293 / 300
页数:7
相关论文
共 331 条
[1]  
Bevers EM(1991)Lupus anticoagulant IgG’s [LA] are not directed to phospholipids only but to a complex of lipid-bound human prothrombin Thromb Haemost 66 629-632
[2]  
Galli M(1993)Antiphospholipid antibodies directed against a combination of phospholipids with prothrombin, protein C or protein S: an explanation for their pathogenic mechanism? Blood 81 2618-2625
[3]  
Barbui T(1992)Lupus anticoagulant activity is frequently dependent on the presence of b2-glycoprotein-1 Thromb Haemost 67 499-502
[4]  
Oosting JD(1990)Inhibition of activated protein C and its cofactor protein S by antiphospholipid antibodies Br J Haematol 76 101-107
[5]  
Derksen RH(1987)Kallikrein inhibition and C1-esterase inhibitor levels in patients with the lupus inhibitor Am J Clin Pathol 88 223-228
[6]  
Bobbink IW(1991)The fibrinolytic response to venous occlusion and the natural anticoagulants in patients with antiphospholipid antibodies both with and without systemic lupus erythematosus Br J Haematol 77 354-357
[7]  
Oosting JD(1992)Lupus anticoagulant activity of autoimmune antiphospholipid antibodies is dependent on beta 2-glycoprotein 1 J Clin Invest 90 1100-1104
[8]  
Derksen RH(1994)Autoantibodies to heparin from patients with antiphospholipid antibody syndrome inhibit formation of antithrombin III/ thrombin complexes Blood 83 2389-2391
[9]  
Entjes HT(1993)Autoantibodies to the protein core of vascular basement membrane heparin sulfate proteoglycan in systemic lupus erythematosus Autoimmunity 14 243-249
[10]  
Bouma BN(1996)Antiphospholipid antibodies [aPL] increase the potential monocyte procoagulant activity in patients with systemic lupus erythematosus Lupus 5 206-211